Mitesco

Mitesco ROE

The Return on Equity (ROE) of Mitesco (MITI) as of Oct 18, 2026 is -2.12 %. In the previous year, Return on Equity (ROE) was 9.51 % — a change of -122.34% (lower).

ROE

-2.12 %

YoY

-122.34%

Last updated:

In 2025, Mitesco's return on equity (ROE) was -2.12 %, a -122.34% increase from the 9.51 % ROE in the previous year.

The Mitesco ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
85.55 USD
Jan 1, 2019
167.57 USD
Jan 1, 2020
112.54 USD
Jan 1, 2021
-705.60 USD
Jan 1, 2022
121.42 USD
Jan 1, 2023
94.34 USD
Jan 1, 2024
9.51 USD
Jan 1, 2025
-2.12 USD
The Mitesco ROE history
YEARROEYoY
-2.12 %-122.34%
9.51 %-89.92%
94.34 %-22.30%
121.42 %-117.21%
-705.60 %-726.98%
112.54 %-32.84%
167.57 %+95.86%
85.55 %+57.40%
54.36 %-88.13%
457.88 %+490.44%
77.55 %-53.42%
166.49 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Mitesco Stock analysis

What does Mitesco do? Mitesco Inc is a U.S. company based in Deephaven with 24 employees. It operates in the Health Care sector and engages in the development, production, and sale of pharmaceuticals. The company went public on November 3, 2011. Mitesco Inc. is the operator of The Good Clinic and focuses on developing healthcare technology solutions. Its North American operations are managed by Mitesco N.A. LLC, a holding company. The company aims to improve healthcare quality and reduce costs through technology integration. Mitesco is one of the most popular companies on Eulerpool.

ROE Details

Decoding Mitesco's Return on Equity (ROE)

Mitesco's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Mitesco's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Mitesco's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Mitesco’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Mitesco stock

Return on Equity (ROE) of Mitesco is -2.12 % in 2025.

Return on Equity (ROE) of Mitesco changed from 9.51 % to -2.12 %, representing a -122.34% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Mitesco since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Mitesco with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Mitesco

All Key Metrics — Mitesco